Rio Tinto (NYSE:RIO) said Thursday it plans to spend US$1.2B to modernize its Isle-Maligne hydroelectric power plant, commissioned in 1926, in Quebec, which it said is needed to secure the long ...

Second baseman/outfielder Tony Kemp announced his retirement from Major League Baseball on Thursday after nine seasons. Kemp, 33, played with the Houston Astros (2016-19), Chicago Cubs (2019 ...

Novo Nordisk A/S is partnering with U.S. biotech Septerna Inc. on the development of oral pills for obesity in a deal potentially worth up to $2.2 billion. The two companies will start with four ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — GSK said Wednesday it would purchase an experimental liver ...

Novo Nordisk is making yet another bet on obesity, offering Septerna more than $200 million in upfront and near-term payments for rights to preclinical oral small molecules that hit targets ...

British pharmaceutical company GSK (NYSE:GSK) to acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa, for as much as $2 billion in cash. Under the agreement, GSK will pay $1.2 billion ...

President Donald Trump was confronted aboard Air Force One by New York Times White House reporter Jonathan Swan over a $2 billion foreign deal that’s being paid for with Trump crypto. Trump is ...

A trial court ruling against the Trump administration Tuesday affirmed the U.S. Department of State and government officials cannot withhold $2 billion in foreign assistance owed to partner groups ...

Gov. Kathy Hochul signed the largest New York state budget in history into law last week for fiscal year 2026, committing billions to Medicaid and expanding health care protections for pregnant ...

Two life sciences manufacturing hubs are coming to fruition in the U.S., adding to the wave of projects sparked by President Donald Trump's domestic manufacturing push. Biotech company Greentech ...

New York's attorney general is reviving a major consumer protection case that federal regulators dropped shortly after President Donald Trump returned to office. Attorney General Letitia James ...

GSK secures rights to Boston Pharmaceuticals’ efimosfermin alfa, which the pharma plans to develop for fatty liver diseases such as metabolic dysfunction-associated steatohepatitis and alcohol-related ...